Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.14
Latest analyst grade actions
1234 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 49.40 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 65.74 | Oscillator | Neutral |
| Williams %R (14) | -38.39 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.01 (Hist 0.00) | Oscillator | Buy |
| Average Directional Index (14) | 25.86 (+DI 22.7 / -DI 21.3) | Trend |
| EMA 20 | 0.14 | MA | Buy |
| SMA 20 | 0.14 | MA | Buy |
| EMA 50 | 0.16 | MA | Strong Sell |
| SMA 50 | 0.17 | MA | Strong Sell |
| SMA 200 | 0.23 | MA | Strong Sell |
FY2024 · 10-K disclosure
Stock news · updated daily
US Regulatory Landscape Has Improved Dramatically in Recent Months; Charlie's is Positioned to Capitalize. In NicQuid v. FDA, the Fifth Circuit issued what could be the most important legal development for Charlie's Premarket Tobacco Application ("PMTA") portfolio in years;The FDA identified 30 of Charlie's PMTA-pending products for inclusion on a proposed public-facing webpage that identifies products for which the FDA generally does not intend to prioritize enforcement;Most importantly, the FDA has now validated "age-gating" as a pathway for flavored electronic nicotine delivery ("ENDS") products; Charlie's is on pace to launch America's first age-gated flavored disposable vapes this year.
Insiders Purchased $270,000 of Common Equity in First Half of 2026 COSTA MESA, CA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Charlie's Holdings, Inc. (OTCQB: CHUC ) (“Charlie's” or the “Company”), an industry leader in the premium vapor products space, reported results for the three months ended June 30, 2026, and provided an update on recent business highlights. Key Financial Highlights for Q2 2026 (compared with Q2 2025) Revenue increased 116% to $3.8 million Gross profit increased 130% to $1.1 million Gross margin improved to 29.4% Operating loss increased 29% to $1.2 million Key Balance Sheet Highlights for Q2 2026 (compared with Year End 2025) Cash balance of $0.5 million, compared to $1.3 million Total assets of $12.8 million, compared to $11.6 million Total shareholders' equity of $3.1 million, compared to $3.4 million Management Commentary “We are pleased to announce that the FDA recently notified us that certain of our PACHA products - 30 SKUs - for which PMTAs have been submitted have been tentatively identified for inclusion on the FDA's public-facing webpage of products for which the FDA generally does not intend to prioritize enforcement of PMTA requirements.
COSTA MESA, CA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Charlie's Holdings, Inc. (OTCQB: CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, announced today that Charlie's Board of Directors has named, effective immediately, Henry Sicignano, III, Chief Executive Officer.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 17, 2026 | — | -0.01 | — | $3.80M |
| May 20, 2026 | — | -0.00 | — | $4.80M |
| Mar 31, 2026 | — | 0.00 | — | $8.98M |
| Nov 19, 2025 | — | 0.00 | — | $7.08M |
| Aug 21, 2025 | — | 0.02 | — | $2.54M |
| Jun 27, 2025 | — | -0.00 | — | $2.31M |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 3, 26 | Sicignano Henry Iii | officer: President | A-Award | 500,000 | — |
| Sep 3, 26 |
| Montesano Matthew P |
| officer: Chief Financial Officer |
| A-Award |
| 500,000 |
| — |
| Sep 3, 26 | Stump Ryan | officer: Chief Operating Officer | A-Award | 200,000 | — |
| Sep 3, 26 | King Michael D | director | A-Award | 200,000 | — |
| Sep 3, 26 | Fox Jeffrey G | director | A-Award | 200,000 | — |
| Sep 3, 26 | Cohen Scot | director | A-Award | 200,000 | — |
| Sep 3, 26 | Carmines Edward | director | A-Award | 200,000 | — |
| Feb 13, 26 | Stump Ryan | officer: Chief Operating Officer | P-Purchase | 250,000 @ $0.20 | $50.00K |
| 4 | Sep 4, 2026 | 2026-09-04 17:48:50 | View |
| 4 | Sep 4, 2026 | 2026-09-04 17:45:22 | View |
| 4 | Sep 4, 2026 | 2026-09-04 17:40:31 | View |
| 10-Q | Aug 17, 2026 | 2026-08-17 16:16:04 | View |
| NT 10-Q | Aug 14, 2026 | 2026-08-14 17:22:22 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 17:24:13 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | CHUC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -19.7x | -1.4x · sector 38.2x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | 12.2x | -40.8x | Discount |
| Price / Sales | 1.6x | 1.8x | In line |
| EV / EBITDA | -27.2x | -4.9x | Elevated |
| Return on equity | -60.7% | — | Weak |
| Gross margin | 27.4% | 37.5% | Below hist. |
| Debt / Equity | 0.16 | -5.15 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 3.19 | Safe zone |
Discounted cash flow model